Persistence of recipient-derived as well as donor-derived clones of cytomegalovirus pp65-specific cytotoxic T cells long after allogeneic hematopoietic stem cell transplantation

Transpl Infect Dis. 2014 Dec;16(6):930-40. doi: 10.1111/tid.12318. Epub 2014 Nov 28.

Abstract

Background: Cytomegalovirus (CMV)-specific CD8(+) cytotoxic T lymphocytes (CMV-CTLs) play a crucial role in preventing CMV disease. However, the actual in vivo dynamics of CMV-CTL clones after allogeneic hematopoietic stem cell transplantation (alloHCT) are still unclear.

Methods: Using a single-cell T-cell receptor repertoire analysis, we monitored clones and chimerism of CMV-CTLs in 3 CMV-seropositive alloHCT recipients from CMV-seronegative donors, with or without CMV reactivation.

Results: Nearly all of the CMV-CTLs during follow-up were CD45RA(-) CCR7(-) effector memory/CD45RA(+) CCR7(-) effector T cells, and were highly matured. In each case, the use of BV gene families was restricted, especially in BV5, 7, 28, and 29. Although no common predominant CMV-CTL clones were found, several shared motifs of complementarity-determining region-3 were identified among the 3 cases; QGA in all, TGE and TDT in Case 1 and Case 2, and RDRG in Case 2 and Case 3. In all cases, CMV-CTL clones that were detected for the first time after alloHCT persisted as the dominant clones. In Case 1, without CMV reactivation, recipient-derived CMV-CTLs exclusively persisted as a dominant clone, while all CMV-CTLs in the other 2 cases, with CMV reactivation, were donor derived.

Conclusion: Clone monitoring and chimerism analyses should help to further clarify novel aspects of immuno-reconstitution after alloHCT.

Keywords: CMV; CTL; HLA-A*2402-restricted cytomegalovirus-specific cytotoxic T cells; T cell receptor-β; chimerism analysis; clone monitoring; single-cell analysis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cytomegalovirus*
  • Female
  • Gene Expression Regulation
  • HLA-A2 Antigen / genetics
  • HLA-A2 Antigen / metabolism
  • HLA-A24 Antigen / genetics
  • HLA-A24 Antigen / metabolism
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / therapeutic use
  • Male
  • Middle Aged
  • Phosphoproteins / immunology*
  • T-Lymphocytes, Cytotoxic / metabolism
  • T-Lymphocytes, Cytotoxic / physiology*
  • Time Factors
  • Tissue Donors*
  • Viral Matrix Proteins / immunology*
  • Young Adult

Substances

  • HLA-A*24:02 antigen
  • HLA-A2 Antigen
  • HLA-A24 Antigen
  • Immunosuppressive Agents
  • Phosphoproteins
  • Viral Matrix Proteins
  • cytomegalovirus matrix protein 65kDa